The effect of estradiol
The human endometrium, the site of nidation is especially important as the nutritional source of the fertilized ovum. It is controlled cyclically by the ovarian steroid hormones such as estrogen and progesterone. The glycogen in the endometrium is one of the most important factors in the development of the blastocytes in the early stages of gestation. The glycogen content of the endometrium in certain infertile women is reported to be greatly reduced (Maeyama et al., 1977) .
Progesterone is regarded as playing a key role in glycogen synthesis in the endometrial tissues (Arronet et al., 1957) . But the precise regulatory mechanism of glycogen synthesis is not known. To elucidate this mechanism, we established a primary cell culture system of human endometrial cells in which cultured cells are capable of producing glycogen in response to various hormones. Therefore this cell culture system provides a good tool to explore the hormonal regulatory mechanism of glycogen synthesis at the cellular level.
We have already reported the stimulatory action of progesterone in the synthesis of glycogen in this cell culture system (Ishihara et al., 1988) . In this study, we further investigated the effect of estradiol on glycogen metabolism in the endometrium. After 24hours of incubation, the culture medium was changed, and the culture was continued with medium containing hormones as indicated.
Glycogen phosphorylase activities were assayed as described before.*p<0.05.
Discussion
Our previous results demonstrated that progesterone increased the content of glycogen in a cell culture system of human endometrium (Ishihara et al., 1988) . The mechanism of the stimulatory actions of progesterone was shown to be an increase in the glycogen synthetase activity and a concomitant decrease in the glycogen phosphorylase activity. On the other hand, the present study indicates that estradiol exerts an inhibitory effect on the glycogen irrespective of the presence of progesterone. The inhibitory effect of estradiol on glycogen content appears to be, in part, due to the lowered level of glycogen synthetase. When cycloheximide was added together with estradiol to the medium, the inhibitory action of estradiol was completely abolished (data not shown here), indicating that the decrease in the enzymatic activity is mediated by newly synthesized protein.
Glycogen synthetase is known to be present in two interconvertible forms, i. e. active and inactive form. Although estradiol is shown to reduce the total amount of the enzyme, it is to be determined whether or not estradiol changes the ratio of the active form to the inactive form. The effects of estradiol on the glycogen synthesis of endometrial cells seemed to be mediated through its receptor because an antiestrogenic agent by competitive binding to the receptor for estradiol (Kleinberg et al., 1983) blocked the action of estradiol.
The present results may have some physiological relevance in the sense that the inhibitory effect of estradiol is observed at concentration of the hormone available in circulating blood around ovulation. In order to examine whether estradiol actually elicits an inhibitory effect in vivo, estradiol benzoate was given to normally cycling women on day 5 after ovulation. Two days later, glycogen content in the endometrium was found to be reduced to approximately 50% of that in normal women at the same stage of the menstrual cycle (data not described here). It is reasonable to suggest that estradiol directly acts on the endometrium to decrease glycogen content, since a direct effect of estradiol on the corpus luteum is less likely, because, under the experimental conditions, the serum progesterone concentration does not change remarkably. Clinically, inadequate secretion of progesterone is obviously of primary importance as a pathogenic factor in luteal phase defect (Smith et al., 1985) , and it is tempting to speculate that abnormally higher levels of estradiol or an increase in the estradiol/progesterone ratio may be causally related to a decrease in glycogen content in women with a luteal phase defect. Shapiro et al.(1980) described the stimulatory effect of progesterone on the accumulation of endometrial glycogen with an organ culture system of human proliferative endometrium.
However, in their study, the concomitant addition of estradiol with progesterone did not affect the glycogen content in cultured endometrial tissues in contrast with the present results. A reasonable explanation of the discrepancy may be the difference between the culture systems, i. e. one is a cell culture system and the other an organ culture system. In an organ culture system, it is generally difficult to remove hormones, especially hydrophobic hormones, such as steroid hormones, which are present in vivo. Therefore, in vitro experiments using an organ culture system, the effects of the hormones present in vivo are often carried over, even if an organ culture is conducted without the hormones.
One also speculates that the difference may be due to the difference in the phase of the endometrium used, i. e. proliferative phase or secretory phase. Data not presented here clearly demonstrated that estradiol elicits an inhibitory effect on the glycoge content of endometrial cells derived from the proliferative phase as well, thus discounting the difference in the phase as an explanation for disagreements between the results of Shapiro et al. and others.
